SABMiller accelerates promotion of COO to CEO after Chairman falls ill

SABMiller has informed its investors that its Executive Chairman, Graham Mackay, has undergone surgery for a brain tumour and will now embark on a course of treatment.

SABMiller has informed its investors that its Executive Chairman, Graham Mackay, has undergone surgery for a brain tumour and will now embark on a course of treatment.

Accordingly, the company has accelerated the planned promotion of Chief Operating Officer Alan Clark to Chief Executive with immediate effect.

Clark was appointed as Chief Operating Officer in July 2012 with a view to succeeding Mackay as Chief Executive in July 2013 after a transitional period of one year, when it was intended that Mackay would become Non-Executive Chairman.

The group said it will gkeep Mackay's position under review pending the outcome of his treatment, and in the meantime deputy Chairman, John Manser will take up the role of Acting Chairman.

In a note to SABMiller employees, Mackay said: "I am inexpressibly proud of this company, what it has achieved and the shape it is in. I certainly do not expect there to be any impact from this development on its operations or strategic direction, which will continue to run as normal. The transition of management responsibilities to Alan Clark is already well advanced.

"The group is in excellent hands, and Alan will now simply pick up the remaining executive responsibilities a little sooner than expected. I obviously have an additional personal objective, and that is to get well as quickly as possible for the sake of my wife and children. Thank you all for your support."

The share price rose 0.91% to 3,391p by 09:20 on Tuesday.

NR

Recommended

Share tips of the week – 21 January
Share tips

Share tips of the week – 21 January

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
21 Jan 2022
Seven cheap defence stocks to buy now
Share tips

Seven cheap defence stocks to buy now

We’ve got used to a world without war between major powers, but that era is coming to an end as Russia threatens Ukraine and China eyes Taiwan. Buy de…
21 Jan 2022
Invest in VCTs: tax-free investments set to break records
Investment strategy

Invest in VCTs: tax-free investments set to break records

Generous tax breaks make VCTs – venture capital funds – an attractive supplement to pensions.
21 Jan 2022
HubSpot: a tech stock set to tumble
Trading

HubSpot: a tech stock set to tumble

US tech stocks have had a fantastic couple of years. But this year is unlikely to be so bullish for high-fliers that can’t turn big profits.
18 Jan 2022

Most Popular

Ask for a pay rise – everyone else is
Inflation

Ask for a pay rise – everyone else is

As inflation bites and the labour market remains tight, many of the nation's employees are asking for a pay rise. Merryn Somerset Webb explains why yo…
17 Jan 2022
Temple Bar’s Ian Lance and Nick Purves: the essence of value investing
Investment strategy

Temple Bar’s Ian Lance and Nick Purves: the essence of value investing

Ian Lance and Nick Purves of the Temple Bar investment trust explain the essence of “value investing” – buying something for less than its intrinsic v…
14 Jan 2022
Interest rates might rise faster than expected – what does that mean for your money?
Global Economy

Interest rates might rise faster than expected – what does that mean for your money?

The idea that the US Federal Reserve could raise interest rates much earlier than anticipated has upset the markets. John Stepek explains why, and wha…
6 Jan 2022